Summary.
To analyze the degradation system in epidermal cells during their generation, differentiation, and cell death, immunocytochemical localization of lysosomal cysteine and aspartic proteinases, an endogenous cysteine proteinase inhibitor, cystatin ,Q, and ubiquitin were examined using rat sole skin. By confocal laser microscopy, granular immunodeposits for lysosomal proteinases were well demonstrated in epidermal cells; immunoreactivity for cathepsins B and C was prominent in the lower spinous and basal layers, while that for cathepsins L and D was intense in the upper spinous and granular layers, although immunoreactivity for cathepsin D was also detected in the lower epidermal layers. Immunoreactivity for cathepsin H was weakly detected only in the spinous layer, where there were some intensely immunopositive cells with processes which were also immunopositive for S-100a, indicating that these cells were Langerhans cells. Diffuse immunoreactivity for cystatin j9 was intense in the spinous and granular layers and weak in the basal layer. In addition, we also examined the localization of ubiquitin, which is a signal peptide for cytosolic proteolysis;
clear-cut granular immunodeposits for ubiquitin were detected in spinous and granular cells, and some were co-localized with cathepsin B immunoreactivity.
In the basal layer, mitotic cells were strongly immunopositive for ubiquitin. These results suggest that cysteine and aspartic proteinases are involved in the lysosomal system of the epidermis, showing different distributions in the epidermal layers depending on the enzymes examined. Moreover, ubiquitin may be associated with the cell cycle-dependent degradation in basal cells while it also participates in the non-lysosomal proteolysis and probably, lysosomal proteolysis in the spinous and granular cells.
Epidermal cells are known to be generated and mature in the basal layer, eventually migrating upwards in the epidermis to continue to mature in the spinous layer and be flattened in the granular layer, where they undergo apoptosis. Their cellular morphology greatly changes in correspondence with these maturation and dying processes of keratinocytes. This suggests that keratinocytes alter their intracellular metabolic turnover and degradation system as they undergo differentiation, migration, and cell death.
It is well known that there are two intracellular proteolytic pathways: lysosomal and non-lysosomal ones. Old, unneeded proteins in cells are mostly degraded in lysosomes, where cathepsins B, C, H, and L are found as cysteine proteinases and cathepsin D as an aspartic proteinase (KATUNUMA and KOMINAMI, 1983; UCHIYAMA et al., 1994) . These lysosomal cathepsins are widely distributed in mammalian cells (KOMINAMI et al., 1984 (KOMINAMI et al., , 1985 UCHIYAMA et al., 1994) . On the other hand, the non-lysosomal proteolysis system is involved in biologically important processes including metabolic regulation, cell cycle control., and the immune response (CIECHANOVER et al., 1984; GOLDBERG and ROCK, 1992; CIECHANOVER, 1994) . In this system, proteasomes, high molecular mass multisubunit proteinase complexes, have recently been revealed to play major roles (CIECHANOVER, 1994) . Substrates of the proteasomes are required to be enzymatically conjugated by ubiquitin, which is a highly conserved 76 amino acid protein.
Some of lysosomal proteinases have been shown to be localized in epidermal cells (LAZRUS and PooLE, 1975; RINNE et al., 1985; HARA et al., 1993) . We have previously shown that these cysteine and aspartic proteinases are heterogeneous in distribution even in the same tissues such as liver tissue (II et al., 1985; WAGURI et al., 1990) , pancreatic islet endocrine cells (WATANABE et al., 1988) , lung tissue (ISHII et al., 1991) , pituitary tissue (UCHIYAMA et al., 1990 (UCHIYAMA et al., , 1991 , and urinary bladder epithelial cells (TOKUNAGA et al., 1996) . Considering the fact that epidermal keratinocytes differ in their metabolic state as well as morphology depending on their location in the epidermal layers, it may be important to examine the precise localization of each lysosomal proteinase.
Ubiquitin, as stated above, is a cofactor in the soluble ATP-dependent proteolysis for some shortlived and abnormal proteins. Recently, however, it has been shown that Ubiquitin conjugated proteins exist in autolysosomes isolated from the livers of leupeptin-injected rats and from E-64 treated cultured fibroblasts, suggesting that these proteins are degraded not only in the cytosolic proteolytic system but also in the lysosomal system (DOCHERTY et al., 1989; UENO and KOMINAMI, 1991) , Therefore, examination of the localization of ubiquitin in the epidermis may help the understanding of how non-lysosomal proteolysis occurs in cells. The present study analyzed the precise immunohistochemical localization of lysosomal cysteine and aspartic proteinases, and ubiquitin in the epidermis of rat sole skin.
MATERIALS AND METHODS

Animals
Ten adult male Wistar rats (8 weeks of age) were used for the experiments: seven rats for immunohistochemistry and three for Western blotting.
Antibodies
Rabbit antibodies against rat cathepsins B, C, H, and L, cathepsin D, and an endogenous cysteine proteinase inhibitor, cystatin /3 were prepared and purified by affinity chromatography (KOMINAMI et al., 1985; BANDO et al., 1986; OHsAwA et al., 1993) . The anibodies to cathepsins B, C, H, and L were immunologically different and showed no crossreactivity with each other (KOMINAMI et al., 1985) . Rabbit antibodies against ubiquitin, which had been covalently coupled to bovine-y-globulin, were prepared and purified, as previously reported (HAAS and BRIGHT, 1985; UENO and KOMINAMI, 1991) . These antibodies preferentially recognized ubiquitin-protein conjugates on Western blots (UENO and KOMINAMI, 1991) . To identify Langerhans cells in the epidermis, we used a monoclonal antibody against rat S-100a protein (Japan Laboratory for Antibody, Takasaki, Japan).
Western blotting
To examine the presence of cysteine and aspartic proteinases and ubiquitin in the epidermis, immunoblotting was applied to sole skin tissue extracts according to a previously described method (UCHIYAMA et al., 1989) . After decapitation, the sole skin of rats was removed and homogenized with four volumes of 0.05 M Tris-HCl (pH 7.4) with 0.1% Triton X-100, containing proteinase inhibitors (1 mM EDTA, 0.05 mM AMSF, 10pg/ml leupeptin, 10pg/ ml pepstatin, 1 jig/ml Aprotinin A) in a Polytron homogenizer. After centrifugation at 50000 g for 50 min, the supernatants were analyzed by a 12.5% or 16.5% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) under reducing conditions. The proteins were electrophoretically transferred from the polyacrylamide gel to hydrophobic Durapore sheets (Millipore, Tokyo, Japan). The sheets were then incubated with anti-aspartic and -cysteine proteinases, anticystatin /3, and anti-ubiquitin, followed by the same developing procedure used for immunohistochemistry. Incubation with non-immune rabbit serum (1:200) was performed as a control.
Immunohistochemistry
Under anesthetics with pentobarbital (25 mg/kg), rats were perfused first with 100 ml of physiological saline and then with 300 ml of 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2, containing 4% sucrose. Immediately after fixation the sole skin was removed, cut into small pieces and further immersed in the same fixative for 4 h. After cryoprotection with sucrose solutions, the specimens were embedded in OCT compound (Miles Inc., USA) and frozen at -80° C. Cryosections were cut at 7 jim with a cryostat (Sakura CM-501, Tokyo Japan) and mounted on gelatin-coated glass slides.
The cryosections were immunostained by a method described elsewhere (UCHIYAMA et al., 1990) . Briefly, they were treated with 0.3% HZO2 in methanol for 30 min and incubated with 2% normal goat serum for 20 min at room temperature. They were then incubated with the following first antibodies for 24 h at 4C: anti-cathepsin B (0.6 1cg/ml), anti-cathepsin C (11cg/ ml), anti-cathepsin H (0.9ug/ml), anti-cathepsin L (1.1pg/ml), anti-cathepsin D (6.8 jug/ml), anti-cystatin /3 (1:4000), anti-rat S-100cr (1:400), and anti-ubiquitin (0.48 pug/ml. For ordinary light microscopic observations, further incubations were performed with biotinylated goat anti-rabbit IgG (histofine SAB-PO kit. Nichirei; Tokyo, Japan) and peroxidase-conjugated streptavidin (Nichirei) at RT for 20 min. After each step, sections were rinsed thoroughly in 0.1 M phosphate-buffered 0.5 M saline (pH 7.2), containing 0.1% Tween 20 (Sigma; St Louis, MO) (TPBS). Staining for peroxidase was performed using 0.0125% diaminobenzidine (DAB) and 0.002% HZO2 in a 0.05 M Tris-HC1 buffer (pH 7.6) for 10 min. Immunostained sections were viewed with a Nomarski differential interference contrast microscope (Olympus, Tokyo, Japan). For confocal laser scanning microscopic observations, the cryosections treated with various first antibodies were further incubated with fluorescein isothiocyanate (FITC)-conjugated goat antirabbit IgG (1: 500, Seikagaku Inc., Tokyo, Japan) at room temperature for 1 h. The cryosections treated with anti-rat S-100a were incubated with Texas red-conjugated goat anti-mouse IgG (1: 500, Southern Biotechnology Associates, USA) at room temperature for 1 h. In some cryosections, nuclear staining was performed with propidium iodide (PI, 10.ug/ml). Immunofluorescence was viewed with a confocal laser scanning microscope (LSM-GB200, Olympus, Tokyo, Japan).
Control experiments
Control cryosections
were incubated with anticathepsins B, C, H, and L, cathepsin D, and cystatin /3, adsorbed by rat liver cathepsins B, C, H, and L, anti-cathepsin D, and cystatin /3 respectively, or with a non-immune rabbit serum diluted to 1:1000, followed by incubation with biotinylated goat anti-rabbit IgG and streptavidin-peroxidase.
Some sections were directly incubated with the second antibody without any preceding incubation with the first antibodies.
All controls confirmed the specificities of immunoreactivities in light and confocal laser microscopy. Until present, only positive immunostaining for cathepsin H and cathepsin D has been reported (RINNE et al., 1985; HARA et al., 1993) . This study examined the presence of lysosomal cysteine and aspartic proteinases, cystatin /3, and uhiquitin in extracts of rat sole skin, using Western blotting after electrophoretic transfer from SDS-PAGE gels to hydrophobic Durapore sheets. As shown in Figure 1 , protein bands immunoreactive to anti-cathepsin B appeared at 29 kD and 26 kD (single-and heavy-chain forms), that to anti-cathepsin C at 25 kD, and that to anti-cathepsin H at 28 kD (single-chain form). As for protein bands immunoreactive to anti-cathepsins L and D, they were demonstrated not only at their active forms but also at their proforms; protein bands for cathepsin L were seen at 23 kD, 29 kD, and 39 kD (heavy-and single-chain forms and proform), while those for cathepsin D were detected at 31 kD, 43 kD (active forms), and 53 kD (proform). A protein band immunoreactive to anti-cystatin /3 appeared at 12 kD. Moreover, protein bands for ubiquitin were detected as a low molecular band and high molecular smear bands; the former indicated a free form of ubiquitin, and the latter its protein-conjugated forms.
Localization of cysteine and aspartic proteinases as markers for lysosomal proteolysis in epidermal layers
By confocal laser and ordinary light microscopy, immunoreactivity for the cysteine and aspartic proteinases examined was detected in epidermal cells, although its distribution in epidermal layers differed depending on the enzymes examined (Figs. 2, 3) . Granular immunodeposits for cathepsins B and C were prominent in basal and spinous layers . Particularly those for cathepsin C were intensely seen in basal cells (Figs. 2c, d ). Granular immunodeposits for cathepsin H were relatively weak in epidermal cells, but detected in those of the spinous layer. Some cells in the layer demonstrated intense immunoreactivity for cathepsin H, having for cathepsin H was detected in S-100a-immunopositive cells (Fig. 4) , indicating that cathepsin H was intensely localized in Langerhans cells located in the spinous layer. Immunoreactivity for cathepsin L was localized in flattened epidermal cells located in the granular layer (Fig. 2g,  h ). Moreover, granular immunodeposits for cathepsin D were detected in cells throughout the epidermal layers, although they were more intense in the granular layer than in the lower two layers (Fig. 3a, b) .
We have previously demonstrated that an endogenous cysteine proteinase inhibitor, cystatin /3, is specifically localized in macrophages in various tissues including the lung and the synovium of the knee joint (IsHii et al., 1991; ASARI et al., 1995) . Therefore, we expected that cystatin /3 would be specifically localized in Langerhans cells in the epidermis. As shown in Figure 5 , however, immunoreactivity for cystatin /3 was intensely shown in all epidermal cells of each layer, particularly the upper epidermal layers.
Localization of ubiquitin as a marker for nonlysosomal proteolysis in epidermal layers
To examine the cytosolic proteolysis, we further analyzed immunoreactivity for ubiquitin in the epidermis. In the basal layer, immunoreactivity for ubiquitin was strongly localized in mitotic cells, whereas it appeared to be granular in the spinous and granular layers (Fig. 6) . Granular immunodeposits for ubiquitin in the upper epidermal layers resembled those for the cysteine and aspartic proteinases in them. Therefore, we further examined whether ubiquitin is co-localized with lysosomal cysteine proteinases. By confocal laser microscopy, cathepsin Bpositive granules appeared different from ubiquitinimmunopositive materials in epidermal cells, although some were co-localized with each other (Fig.  7a-c) .
To analyze the precise localization of ubiquitin in basal cells during mitosis, double staining for ubiquitin and PI was applied to skin tissue. In general, immunoreactivity for ubiquitin was weak and diffuse in the cytoplasm of the cells in the basal and lower spinous layers. In mitotic cells at various stages such as metaphase, anaphase and telophase, PI staining was intensely positive in chromosomes (Fig. 8c, f, i) , while the immunoreactivity for ubiquitin was mainly detected in the cytoplasmic region except for the chromosomes (Fig. 8a, d, g ). In the peripheral parts of the chromosomes, PI staining was co-localized with the immunoreactivity for ubiquitin (Fig. 8b , e, f). It has been believed that lysosomal cysteine and aspartic proteinases are ubiquitously involved in the degradation system, of various tissue cells (KATUNUMA and KONIINAMI, 1983) . By immunohisto/ cytochemical techniques, however, we have shown that cathepsins B, C, H, and L, and cathepsin D are heterogeneous in distribution even in the same tissues: the pancreatic islet endocrine cells (WATANABF et al., 1988) , the anterior pituitary (UcxJYAMA et al., 1990 (UcxJYAMA et al., , 1991 , the duodenum (FURUHASHI et al., 1991) , the spinal cord (TANIGUCHI et al., 1993) , the submandibular gland (SANO et al., 1993) , and the bladder epithelium (TOKUNAGA et al., 1996) . The present study also found that the localization of these enzymes in the epidermis differed from each other.
It has been shown that various lysosomal enzymes including proteinases are present in the epidermis of various animal species (LAZARUS and POOLE, 1975; MIER and HURK,1976; RINNE et al., 1985; HARA et al., 1993) . Until the present, no immunohistochemical demonstration of cathepsins B and C, which are known as a carboxypeptidase and dipeptidyl aminopeptidase, respectively, has been reported in the epidermis. Using enzyme histochemical techniques, these enzyme activities have been exhibited in basal cell carcinomas of humans (SCHLAGENHAUFF et al., 1992) . The present study showed that immunoreactivity for these two enzymes was predominantly localized in the lower epidermal layers. Particularly intense immunodeposits for cathepsin C were detected in the basal layer. The results suggest that cathepsins B and C play roles in the degradation system of newly generated epidermal cells or those cells early in the differentiating stage.
Cathepsin H, an aminopeptidase, has also biochemically purified from and immunohistochemically demonstrated in the rat skin, vaginal mucosa, and forestomach mucosal area (RINNE et al., 1985) . RINNE et al. (1985) have demonstrated that the localization of cathepsin H predominates in the basal layer of the epidermis. In the present study, however, immunoreactivity for cathepsin H was weak in the epidermis and detected mainly in the spinous layer. The difference in the localization of cathepsin H between the results from RINNE et al. (1985) and ours remains unknown. Our previous studies have shown that immunoreactivity for cathepsin H is often lacking in various tissues including the central nervous tissue (TANIGUCHI et al., 1993) , anterior pituitary tissue (UCHIYAMA et al., 1991) , and duodenal epithelial tissue (FURUHASHI et al., 1991) . Therefore, it seems likely that cathepsin H participates in the specific degradation of cellular metabolites.
Particularly, no immunoreactivity for cathepsin H has been shown in nerve cells of the normal rat spinal cord and gerbil cerebrum (TANIGUCHI et al., 1993; NITATORI et al., 1995 NITATORI et al., , 1996 ; however, it appears in CAl pyramidal neurons and activated microglial cells of the gerbil hippocampus three days after transient forebrain ischemia (NITATORI et al., 1995 (NITATORI et al., , 1996 . Moreover, cathepsin H is often detected in macrophages of various tissues; cathepsin H is not localized in duodenal enterocytes but rather in macrophages in the lamina propria (FURUHASHI et al., 1991) , while it has been shown in perivascular microglia-like cells of the spinal cord (TANIGUCHI et al., 1993) . In the present study, immunoreactivity for cathepsin H was weak in the epidermal cells, but it appeared intensely in S-100x-immunopositive Langerhans cells. Although roles of Langerhans cells may differ from those of macrophages, cathepsin H may play a role in the degradation system of cells relating to the defense mechanism in various tissues, including the epidermis.
We have previously shown that cystatin /3 and cathepsin H are often specifically localized in phagocytic cells of various tissues (ISHII et al., 1991; FURUHASHI et al., 1991; TANIGUCHI et al., 1993; ASARI et al., 1995; NITATORI et al., 1995 NITATORI et al., , 1996 . Therefore, we expected that Langerhans cells, which were intensely immunopositive for cathepsin H, would also be immunopositive for cystatin j3. However, immunoreactivity for cystatin fi was intensely positive in all epidermal cells, so that it was impossible to distinguish Langerhans cells from other epidermal cells by immunostaining for cystatin f3. By biochemical and immunohistochemical techniques, rat epidermis is seen to contain much cystatin a (KOMINAMI et al., 1984; TAKAHASHI et al., 1992) . Unlike an epidermistype cysteine proteinase inhibitor, cystatin a, which is a secretion type protein, cystatin j3 has been purified as a liver-type and cytosolic cysteine proteinase inhibitor and shown to be distributed in various tissues (KOMINAMI et al., 1984) . At present, the precise physiological roles of these cysteine proteinase inhibitors remain to be solved. However, considering the fact that epidermal cells undergo apoptosis in the granular layer and their cell membrane and cytoplasmic organelles disappear from the cells in the cornified layer, cystatins a and f3 may play roles in the inhibition of lysosomal cysteine proteinases which are well localized in granular epidermal cells.
Different from the distribution of cathepsins B, C, and H in the epidermis, immunoreactivity for cathepsins L and D was more intensely detected in the granular layer than in the lower two layers. Immunohistochemistry has demonstrated the localization of cathepsin D in the basal layer of the rabbit epidermis (LAZARUS and POOLE, 1975) , whereas it predominates in the granular layer of rat epidermis (HARA et al., 1993) . Our present data support the results by HARA et al. (1993) , although immunoreactivity for cathepsin D was also detected moderately or weakly in the spinous and basal layers, respectively, in the present study. Biochemical characteristics of cathepsins L and D are different from each other, but both enzymes are specifically localized in osteoclasts of bone tissue (GoTo et al., 1992; OHSAWA et al., 1993) ; they are speculated to play a role in the degradation of collagen molecules in bone tissue, particularly cathepsin L, which is an endopeptidase and different from other cysteine proteinases in its striking capacity to hydrolyze proteins. Corresponding to the maturation process of epidermal cells from the spinous to the granular layers, cathepsins L and D are required to degrade cytoplasmic and membrane bound proteins including intermediate filaments. Specific localization of these lysosomal proteinases may indicate that cathepsins L and D participate in the degradation of proteins in the epidermal cells corresponding to their drastic structural changes.
Usually cathepsins B, C, H, and L, and cathepsin D are present as their active molecular forms in cells, making it difficult to detect their precursor forms. WAGURI et al. (1995) have demonstrated that GH4C1 cells, a rat pituitary tumor cell line, secrete the proform of cathepsin L, and that its localization is perinuclear in the cells. In the present study no epidermal cell exhibited a perinuclear localization of cathepsins L and D. At present, it remains unknown whether epidermal cells, particularly granular epidermal cells, secrete prof orms of these enzymes. The presence of these enzymes in the epidermal cells may simply suggest the active production of these enzymes in the epidermal cells to degrade unneeded proteins resulting from drastic structural alterations in epidermal cells.
The present study examined the distribution of ubiquitin in the epidermis to determine the nonlysosomal degradation system. It is well known that ubiquitin modification of many protein targets within cells plays an important role in a variety of biological processes (CIECHANOVER et al., 1984; CIECHANOVER, 1994) . Particularly, the ubiquitin system has been implicated in the degradation of cyclins which are positive regulatory subunits of protein kinases of the cdc2 family (cyclin-dependent kinases) and consist of A-type and B-type mitotic cyclins, and S-phase, and G1 phase cyclins (HERSHKO, 1996) . Different cyclins are synthesized and degraded at different stages of the cell cycle. In the present study, it was interesting that diffuse ubiquitin immunoreactivity was weak or faint in all basal epidermal cells, except for mitotic cells, which were intensely immunopositive for ubiquitin. Since the ubiquitin-dependent degradation of the cyclin family proteins occurs not only in the mitotic phase but in other phases of the cell cycle, it is not known why ubiquitin immunoreactivity appeared intensely only in mitotic basal cells. Considering the fact that ubiquitin immunoreactivity in mitotic cells at various stages was mainly present in the cytoplasmic region, except for the chromosomes, protein ubiquitination may also occur in cytoskeletal proteins required for mitosis other than cyclins.
Unlike the distribution of ubiquitin immunoreactivity in the basal epidermal layer, granular immunodeposits for it were demonstrated in epidermal cells located in the upper epidermal layers. We have previously demonstrated that granular immunodeposits for ubiquitin are localized in rat and human urinary bladder epithelial cells (TOKUNAGA et al., 1996) ; ubiquitin immunoreactivity is present in cathepsin Bimmunopositive autolysosomes of the epithelial cells. Moreover, ubiquitin conjugated proteins have been shown to exist in autolysosomes isolated from the livers of leupeptin-injected rats and from E-64 treated cultured fibroblasts (DOCHERTY et al., 1989; UEN0 and KOMINAMI,1991) . Using cells with a thermolabile El, a ubiquitin-activating enzyme, LENK et al. (1992) have recently proposed that protein ubiquitination is required for the degradation within autolysosomes. As stated in the Results, granular immunodeposits for ubiquitin in spinous and granular epidermal cells were similar to those for the cysteine and aspartic proteinases examined.
By double immunostaining, however, ubiquitin immunoreactivity was mostly different from cathepsin B immunoreactivity, although some were co-localized with each other. This indicates that ubiquitin-dependent proteolysis through proteasome is responsible mainly for the degradation of cytosolic proteins in the spinous and granular cells, while in some parts, a ubiquitin pathway may also participate in the lysosomal proteolysis.
From the results mentioned above, it is concluded that cathepsins B, C, H, and L, and cathepsin D, cysteine and aspartic proteinases are involved in the lysosomal proteolysis of the epidermis, showing different distributions in the epidermal layers depending on the enzymes examined. This heterogeneous localization of lysosomal cathepsins may largely be associated with the degradation of specific metabolites of epidermal cells undergoing generation, maturation, and cell death. Moreover, the specific localization of ubiquitin immunoreactivity in the epidermis suggests that ubiquitin may be correlated with the cell cycle-dependent degradation in basal cells, while it may participate not only in the nonlysosomal proteolysis but also in lysosomal degradation in the spinous and granular cells.
